All News

A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.

Biosimilars are also expanding rapidly, offering new opportunities for payers, patients, and providers.

Panelists at AXS23 conference agree that the patient’s voice is the most critical, whether it is related to drug manufacturing, delivery, or marketing.

Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.

Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.

Pharmacists will play a growing role in the use of biosimilars and guiding patients through the switching process.

Study shows eplontersen maintains a consistent and sustained treatment effect and reinforces its potential treating hereditary transthyretin-mediated amyloid polyneuropathy, which can lead to heart failure.

Immature data suggest enzalutamide combination improves overall survival in patients with high-risk biochemical recurrence.

Although these programs are not the entire solution to rising pharmacy costs, Marsh said they are an important part of solving the problem.

Recent editorial calls into question role, use of drug coverage for medications that often cost pennies to procure.

Health-system pharmacies should fight the well-orchestrated attempt to dismantle 340B drug pricing.

The law directs federal spending toward funding the internal revenue service, improving taxpayer compliance, lowering health care needs, and reducing carbon emissions.

The system is considered effective at identifying residual breast cancer following surgical resection.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.

The treatment showed significant improvement in patients in patients who require frequent blood transfusions and are at risk of infection.

Naveen Mansukhani, BPharm, discussed skyrocketing prices for specialty drugs and what is driving those increases.

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.

Balancing clinicians’ priorities with the needs of patients and their families is crucial to ensure access and adherence to medications.

Cephalosporin treatment is a risk factor of Clostridioides difficile infection.

Screening tools are becoming widely used to help clinicians address the needs of patients with diabetes to improve health outcomes.

The final approval was based on efficacy and safety data from the phase 3 REST-ON study.

Molidustat oral suspension is also the first approval for cats under the FDA’s expanded conditional approval pathway.

Relative risk of cancer-related death differed according to age of diagnosis.

Pharmacists play key roles in navigating prior authorizations and other limits on utilization, as well as educating and listening to patients and caregivers.

Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.

Key topics in May include mental illness for pharmacists, pharmacy technicians, and PharmD candidates.

Session at the 2023 Asembia Summit notes that pharmacists play a particularly important role in the large multidisciplinary care team needed for Rett syndrome management.

Issues highlighted in May include mental illness as well as asthma and allergies.